BNT162b2 LP.8.1-adapted vaccine against SARS-CoV-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BNT162b2 LP.8.1-adapted vaccine against SARS-CoV-2, covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19 [Phase 3]